These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 828819)

  • 1. [Protective properties of gonococcal vaccines].
    Ovchinnikov NM; Timchenko GF
    Vestn Dermatol Venerol; 1976 Dec; (12):28-32. PubMed ID: 828819
    [No Abstract]   [Full Text] [Related]  

  • 2. Common heat stable protective antigen in gonococci.
    Ito JI; Corbeil LB; Wunderlich AC; McCutchan JA; Braude AI
    Trans Assoc Am Physicians; 1979; 92():160-8. PubMed ID: 95067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ways and prospects of producing gonococcal vaccine].
    Bednova VN; Dmitriev GA; Pasternak NI
    Vestn Dermatol Venerol; 1987; (11):41-7. PubMed ID: 3125694
    [No Abstract]   [Full Text] [Related]  

  • 4. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.
    Wetzler LM; Blake MS; Gotschlich EC
    Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary studies on the development of a gonococcal vaccine.
    Greenberg I; Diena BB; Kenny CP; Znamirowski R
    Bull World Health Organ; 1971; 45(4):531-5. PubMed ID: 5004708
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine research for gonococcal infections: where are we?
    Jerse AE; Deal CD
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv63-8. PubMed ID: 24243883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a gonococcal cell-wall lectin-adhesin with vaccine potential.
    Perrollet H; Guinet RM
    Ann Sclavo Collana Monogr; 1986; 3(1-2):399-406. PubMed ID: 3122804
    [No Abstract]   [Full Text] [Related]  

  • 8. Human experimentation with Neisseria gonorrhoeae: progress and goals.
    Cohen MS; Cannon JG
    J Infect Dis; 1999 Mar; 179 Suppl 2():S375-9. PubMed ID: 10081510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.
    Piekarowicz A; Kłyż A; Majchrzak M; Stein DC
    Sci Rep; 2016 Mar; 6():22549. PubMed ID: 26939573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
    Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
    Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Some aspects of the study of gonorrhea vaccine].
    He F; Zhao L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):248-50. PubMed ID: 10322765
    [No Abstract]   [Full Text] [Related]  

  • 13. Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.
    Edwards JL; Jennings MP; Apicella MA; Seib KL
    Crit Rev Microbiol; 2016 Nov; 42(6):928-41. PubMed ID: 26805040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems posed by potential gonococcal vaccines viewed from the vantage point of a control agency.
    Robbins JB
    Br J Vener Dis; 1977 Jun; 53(3):170-2. PubMed ID: 406011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for gonorrhea: where are we on the curve?
    Blake MS; Wetzler LM
    Trends Microbiol; 1995 Dec; 3(12):469-74. PubMed ID: 8800838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic efficacy of a gonococcal vaccine].
    Andreeva ZM; Bednova VN; Shevchenko NM; Malyshev AM; Danilenko TI
    Vestn Dermatol Venerol; 1989; (11):53-5. PubMed ID: 2515676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic composition of the gonococcal strains used in preparing a gonorrhea vaccine].
    Andreeva ZM; Shevchenko NM
    Vestn Dermatol Venerol; 1986; (7):33-5. PubMed ID: 3094267
    [No Abstract]   [Full Text] [Related]  

  • 18. Probing the surface of Neisseria gonorrhoeae: simultaneous localization of protein I and H.8 antigens.
    Robinson EN; McGee ZA; Buchanan TM; Blake MS; Hitchcock PJ
    Infect Immun; 1987 May; 55(5):1190-7. PubMed ID: 3106215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonococcal vaccine studies in Inuvik.
    Greenberg L; Diena BB; Ashton FA; Wallace R; Kenny CP; Znamirowski R; Ferrari H; Atkinson J
    Can J Public Health; 1974; 65(1):29-33. PubMed ID: 4205640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined treatment of women with chronic gonorrhea using gonovaccine, methyluracil and Ampiox].
    Kuznetsova VG
    Vestn Dermatol Venerol; 1982 Oct; (10):56-9. PubMed ID: 6817537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.